CSL FPO (ASX: CSL) Share Price and News
Chart and Price Data
|Avg Daily Volume|
|52 Week Range||-|
|Year Return (Capital)|
CSL Limited (CSL) is a global biotechnology company that develops and delivers innovative biotherapies and influenza vaccines to protect public health and help people with life-threatening medical conditions live full lives.
While the company has been in operation for more than a century, CSL shares were first listed on the ASX in 1994 within the healthcare sector – today, CSL sits as one of the largest companies on the ASX. The CSL share price has risen exponentially since first listing on the ASX and is now considered a traditional growth stock – CSL is known to lift profit, year-on-year, and invest much of it back into research and development and capital expenditure.
CSL’s operational businesses include CSL Behring and Seqirus, and the company operates predominantly in Australia, the USA, Germany, the United Kingdom and Switzerland.
CSL FPO (ASX: CSL) Latest News
Tom Richardson | November 11, 2019 4:33pm
The CSL share price is rising again today after leading analysts at UBS tipped that it could reach $295. More »
Lina Lim | November 11, 2019 3:20pm
Are the CSL Ltd (ASX: CSL) and ResMed Inc (ASX: RMD) share prices a buy? More »
Tristan Harrison | November 6, 2019 8:20am
The factor I talk about in this article could be the biggest reason why some ASX shares like Altium Limited (ASX:ALU) make huge returns.... More »
Sebastian Bowen | November 5, 2019 7:41pm
Is the Australian Foundation Investment Co Ltd (ASX: AFI) share price a good investment? More »